← Back to General Health studies
Enrolling now

A study for adults living with chronic hives (chronic spontaneous urticaria)

An early-stage study testing whether an investigational epinephrine nasal spray helps ease hive-flare symptoms in people already on hive medication.

What to expect

Screening visit to confirm eligibility

Short run-in period tracking flares

Self-administer the investigational nasal spray during flares

Log symptoms and photos daily in a smartphone app

Scheduled clinic check-ins

You may be a fit if

✓

Age 18–65

✓

Doctor's diagnosis of chronic hives

✓

Moderate-to-severe flares roughly monthly despite medication

✓

On current treatment for at least 6 weeks

✓

Able to use a smartphone app

More about this study

Read the full details, including what taking part involves and answers to common questions, on the study's information page.

Registry details

This study is registered as NCT06927999: see every site, the full eligibility criteria and the official record.

SiteBirmingham, AL
Available inAL
WhoAdults 18–65 with chronic hives and moderate-to-severe monthly flares despite treatment
TimeScreening + run-in, daily app logging, scheduled clinic visits
CompensationCompensation provided (study visits and medicine at no cost)
Check if I qualify

A few quick questions. No obligation, and your answers stay private.